knowledge -WSS

knowledge

author：focus 2025-10-02 00:27:59 - browse：7245

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Medicare drug price negotiation continues, as pharma counteroffers

WSS

Police still searching for prisoner who escaped from NYC hospital

The untold story of TV’s first prescription drug ad

He's 19 months old and has one of the world’s rarest diseases

Wegovy trial has doctors encouraged over new possibilities

Harvard's David Sinclair gets blowback over aging

Families look for replacement for GSK asthma drug Flovent

hotspot

knowledge

explore

Medical records are filled with copy

Fetal cell organoids grown from amniotic fluid, study finds

Virginia high school admissions case could be legal follow

Drastic changes should bring profitability, startup health insurers say

Jerome Adams on the need for new antivirals for Covid

Naloxone nonprofit donates 200,000 doses after FDA approval

Wildfire smoke exposes gaps in outdoor worker protections

The untold story of TV’s first prescription drug ad

Anesthesiologist group: stop taking Ozempic before surgery

Lack of health data on LGBTQ+ people has serious consequences

focus

Naloxone nonprofit donates 200,000 doses after FDA approval

The untold story of TV’s first prescription drug ad

Police still searching for prisoner who escaped from NYC hospital

Florida health officials providing scant details on measles cases

Methadone doses haven’t kept up in the age of fentanyl

A new approach to psychiatric drug development

Wikipedia

leisure time

hotspot

Wikipedia